Surmodics Inc (SRDX)

27.43
NASDAQ : Health Care
Prev Close 25.85
Day Low/High 23.47 / 27.59
52 Wk Low/High 17.45 / 27.68
Avg Volume 65.70K
Exchange NASDAQ
Shares Outstanding 13.01M
Market Cap 336.44M
EPS 0.90
P/E Ratio 23.50
Div & Yield N.A. (N.A)

Latest News

Insider Trading Alert - FRED, WLFC And SRDX Traded By Insiders

Insider Trading Alert - FRED, WLFC And SRDX Traded By Insiders

Stocks with insider trader activity include FRED, WLFC and SRDX

SurModics To Present At Jefferies Healthcare Conference

SurModics To Present At Jefferies Healthcare Conference

SurModics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies, today announced that Gary Maharaj, president and chief executive officer, and Andy LaFrence, vice president of...

SurModics Reports Second Quarter Fiscal 2016 Results

SurModics Reports Second Quarter Fiscal 2016 Results

SurModics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2016 second quarter, ended March 31, 2016.

SurModics To Webcast Second Quarter 2016 Earnings Conference Call On May 2

SurModics To Webcast Second Quarter 2016 Earnings Conference Call On May 2

SurModics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it will host a live webcast of its second quarter fiscal 2016...

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AIRM, AKS, AVX, AWH, BWA, CPHD, CVV, DD, EMXX, MAS, NANO, NTP, PEBO, PMD, PNR, POL, QLIK, SRDX, STAY, TILE, WCC, WWW, ZIXI Downgrades: ARI, CTG, STL Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

SurModics Announces First Patient Enrolled In IDE Study Of SurVeil™ Drug-Coated Balloon

SurModics Announces First Patient Enrolled In IDE Study Of SurVeil™ Drug-Coated Balloon

SurModics, Inc. (Nasdaq:SRDX), a leading provider of medical devices and in vitro diagnostic technologies, today announced enrollment of the first patient in an early feasibility study of its proprietary SurVeil™...

Insider Trading Alert - DLR, SRDX And WCG Traded By Insiders

Insider Trading Alert - DLR, SRDX And WCG Traded By Insiders

Stocks with insider trader activity include DLR, SRDX and WCG

SurModics To Host Virtual Shareholder Meeting On February 17

SurModics To Host Virtual Shareholder Meeting On February 17

SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface modification and in vitro diagnostic technologies to the healthcare industry, announced today that it will host a live webcast of its Annual Meeting of...

SurModics Reports First Quarter Fiscal 2016 Results

SurModics Reports First Quarter Fiscal 2016 Results

SurModics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2016 first quarter, ended December 31, 2015.

SurModics To Webcast First Quarter 2016 Earnings Conference Call On January 28

SurModics To Webcast First Quarter 2016 Earnings Conference Call On January 28

SurModics, Inc. (Nasdaq:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, announced today that it will host a live webcast of its first quarter fiscal 2016...

See How SurModics Ranks Among Analysts' Top Picks With Strong Buyback Activity

See How SurModics Ranks Among Analysts' Top Picks With Strong Buyback Activity

A study of analyst recommendations at the major brokerages shows that SurModics, Inc. is the #8 broker analyst pick among those stocks screened by The Online Investor for strong stock buyback activity.

SurModics Acquires NorMedix, A Design And Development Company Focused On Minimally Invasive Catheter Technologies

SurModics Acquires NorMedix, A Design And Development Company Focused On Minimally Invasive Catheter Technologies

SurModics, Inc. (Nasdaq:SRDX), a leading provider of medical device and in vitro diagnostic technologies, today announced it has acquired NorMedix, Inc.

SurModics Is Now Oversold (SRDX)

SurModics Is Now Oversold (SRDX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

SurModics Provides Updated 2016 Guidance

SurModics Provides Updated 2016 Guidance

SurModics, Inc. (Nasdaq:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced updated guidance for the year ending September 30, 2016.

SurModics To Webcast Updated Fiscal 2016 Financial Guidance Conference Call On January 8

SurModics To Webcast Updated Fiscal 2016 Financial Guidance Conference Call On January 8

SurModics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, announced today that it will host a live webcast on Friday, January 8, at 7:30 a.

SurModics Announces Device Veteran Shawn McCormick Joins Board Of Directors

SurModics Announces Device Veteran Shawn McCormick Joins Board Of Directors

SurModics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies, today announced the addition of a new independent board member, Shawn McCormick, a highly experienced medical device...

Insider Trading Alert - SRDX, SSI And KRO Traded By Insiders

Insider Trading Alert - SRDX, SSI And KRO Traded By Insiders

Stocks with insider trader activity include SRDX, SSI and KRO

SurModics To Present At Oppenheimer Healthcare Conference

SurModics To Present At Oppenheimer Healthcare Conference

SurModics, Inc. (Nasdaq:SRDX), a leading provider of medical device and in vitro diagnostic technologies, today announced that Gary Maharaj, president and chief executive officer, and Andy LaFrence, vice president of...

SurModics Acquires Creagh Medical, A Developer And Manufacturer Of Balloon Catheters

SurModics Acquires Creagh Medical, A Developer And Manufacturer Of Balloon Catheters

SurModics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies, today announced it has acquired Creagh Medical Ltd.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ADT, AIN, BDBD, CBS.A, CRAY, EGT, FPRX, GERN, HMPR, ISIL, SCLN Downgrades: ASM, BRS, SRDX Initiations: DPLO, W Read on to get TheStreet Quant Ratings' detailed report:

SurModics To Present At Canaccord Genuity Medical Technology And Diagnostics Forum

SurModics To Present At Canaccord Genuity Medical Technology And Diagnostics Forum

SurModics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, announced today that Gary Maharaj, president and chief executive officer, and Andy...

SurModics Reports Fourth Quarter Fiscal 2015 Results

SurModics Reports Fourth Quarter Fiscal 2015 Results

SurModics, Inc. (Nasdaq:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2015 fourth quarter, ended September 30, 2015.

SurModics To Webcast Fourth Quarter And Fiscal Year 2015 Earnings Conference Call On November 10

SurModics To Webcast Fourth Quarter And Fiscal Year 2015 Earnings Conference Call On November 10

SurModics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, announced today that it will host a live webcast of its fourth quarter and fiscal year...

Analyst Favorites With Strong Buyback Activity: SurModics Ranks As a Top Pick

Analyst Favorites With Strong Buyback Activity: SurModics Ranks As a Top Pick

A study of analyst recommendations at the major brokerages shows that SurModics, Inc. is the #8 broker analyst pick among those stocks screened by The Online Investor for strong stock buyback activity.

SurModics Receives FDA IDE Approval For Early Feasibility Study Of The SurVeil™ Drug-Coated Balloon

SurModics Receives FDA IDE Approval For Early Feasibility Study Of The SurVeil™ Drug-Coated Balloon

SurModics, Inc. (Nasdaq:SRDX), a leading provider of medical device and in vitro diagnostic technologies, today announced that it has received U.

Commit To Purchase SurModics At $22.50, Earn 13.7% Annualized Using Options

Commit To Purchase SurModics At $22.50, Earn 13.7% Annualized Using Options

Investors considering a purchase of SurModics, Inc. shares, but cautious about paying the going market price of $23.64/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Insider Trading Alert - COTY, SPKE And SRDX Traded By Insiders

Insider Trading Alert - COTY, SPKE And SRDX Traded By Insiders

Stocks with insider trader activity include COTY, SPKE and SRDX

See How SurModics Ranks Among Analysts' Top Picks With Strong Buyback Activity

See How SurModics Ranks Among Analysts' Top Picks With Strong Buyback Activity

A study of analyst recommendations at the major brokerages shows that SurModics, Inc. is the #9 broker analyst pick among those stocks screened by The Online Investor for strong stock buyback activity.